arrow
Back
T

Tasuku Honjo

kyoto university

143H-index
737Paper Count
9.6WCitation Count
Published Papers 228
Publication Date
Active aldehydes accelerate CD8+ T cell exhaustion by metabolic alteration in the tumor microenvironment
err2026-01-07
err0
PREAI
errYasuharu Haku; Koji Kitaoka; Koki Ichimaru; Tomoko Hirano; Jun Wang; Kazuhiro Sonomura; Asuka Maruo; Shuhei Hirose; Yu Wang; Katsuhiro Ito; Tomohiro Kozuki; Keiko Yurimoto; Mai Kiyono; Hidetaka Kosako; Toshi Menju; Hiroshi Date; Takashi Kobayashi; Koichi Omori; Tomonori Yaguchi; Tasuku Honjo; Kenji Chamoto
errShare
errSave
Chimeric MHC class I- and II-restricted non-self epitopes broaden antitumor T cell reactions
err2025-12-05
err1
PREAI
errZhang, Rongsheng; Ma, Rong; Leong, Merrin M. L.; Watson, Ian R.; Iida, Kei; Yaguchi, Tomonori; Matsuda, Fumihiko; Honjo, Tasuku; Chamoto, Kenji
errShare
errSave
PD-1 suppresses germinal center reaction and affinity maturation of antibodies
err2025-11-01
err0
PREAI
errTokumaru, Yosuke; Nakajima, Yuka; Suzuki, Kensuke; Honjo, Tasuku; Ohta, Akio
errShare
errSave
hnRNPL–CstF64 complex: coordinating CSR and LSR in IgH locus recombination dynamics through eRNA and NHEJ regulation
err2025-09-03
err0
errOAAI
errFarazul Haque; Mikiyo Nakata; Hidetaka Kosako; Tasuku Honjo; Nasim A Begum
errShare
errSave
Blocking S100A9-signaling is detrimental to the initiation of anti-tumor immunity
err2024-10-21
err1
errOAAI
errDemir, Melike Fusun; Lin, Yu-Hsien; Costa Cruz, Pedro Henrique; Tajima, Masaki; Honjo, Tasuku; Mueller, Elisabeth
errShare
errSave
Chemoproteomic Identification of Spermidine-Binding Proteins and Antitumor-Immunity Activators
err2024-06-07
err2
PREAI
errSingh, Vaibhav Pal; Hirose, Shuhei; Takemoto, Misao; Farrag, Asmaa M. A. S.; Sato, Shin-ichi; Honjo, Tasuku; Chamoto, Kenji; Uesugi, Motonari
errShare
errSave
Spermidine - an old molecule with a new age-defying immune function
err2024-05-01
err4
errOAAI
errChamoto, Kenji; Zhang, Baihao; Tajima, Masaki; Honjo, Tasuku; Fagarasan, Sidonia
errShare
errSave
BRD2 promotes antibody class switch recombination by facilitating DNA repair in collaboration with NIPBL
err2024-04-03
err1
errOAAI
errGothwal, Santosh K.; Refaat, Ahmed M.; Nakata, Mikiyo; Stanlie, Andre; Honjo, Tasuku; Begum, Nasim A.
errShare
errSave
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade
err2024-04-01
err3
errOAAI
errHayashi, Hidetoshi; Chamoto, Kenji; Hatae, Ryusuke; Kurosaki, Takashi; Togashi, Yosuke; Fukuoka, Kazuya; Coto, Megumi; Chiba, Yasutaka; Tomida, Shuta; Ota, Takayo; Haratani, Koji; Takahama, Takayuki; Tanizaki, Junko; Yoshida, Takeshi; Iwasa, Tsutomu; Tanaka, Kaoru; Takeda, Masayuki; Hirano, Tomoko; Yoshida, Hironori; Ozasa, Hiroaki; Sakamori, Yuichi; Sakai, Kazuko; Higuchi, Keiko; Uga, Hitoshi; Suminaka, Chihiro; Hirai, Toyohiro; Nishio, Kazuto; Nakagawa, Kazuhiko; Honjo, Tasuku
errShare
errSave
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study
err2023-12-11
err8
errOAAI
errKurosaki, Takashi; Chamoto, Kenji; Suzuki, Shinichiro; Kanemura, Hiroaki; Mitani, Seiichiro; Tanaka, Kaoru; Kawakami, Hisato; Kishimoto, Yo; Haku, Yasuharu; Ito, Katsuhiro; Sato, Toshiyuki; Suminaka, Chihiro; Yamaki, Mami; Chiba, Yasutaka; Yaguchi, Tomonori; Omori, Koichi; Kobayashi, Takashi; Nakagawa, Kazuhiko; Honjo, Tasuku; Hayashi, Hidetoshi
errShare
errSave
Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy
err2023-12-01
err0
errOAAI
errTanizaki, Junko; Kuroda, Hiroaki; Yokoyama, Toshihide; Takahama, Makoto; Shoda, Hiroyasu; Nakamura, Atsushi; Kitamura, Yoshitaka; Mamesaya, Nobuaki; Kadota, Yoshihisa; Sawa, Kenji; Okishio, Kyoichi; Okada, Morihito; Suminaka, Chihiro; Noda, Kenta; Sakai, Kazuko; Chiba, Yasutaka; Nishio, Kazuto; Chamoto, Kenji; Honjo, Tasuku; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Hayashi, Hidetoshi
errShare
errSave
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial*
err2023-05-01
err7
PREAI
errKawakami, Hisato; Sunakawa, Yu; Inoue, Eisuke; Matoba, Ryo; Noda, Kenta; Sato, Toshiyuki; Suminaka, Chihiro; Yamaki, Mami; Sakamoto, Yasuhiro; Kawabata, Ryohei; Ishiguro, Atsushi; Akamaru, Yusuke; Kito, Yosuke; Yabusaki, Hiroshi; Matsuyama, Jin; Takahashi, Masazumi; Makiyama, Akitaka; Hayashi, Hidetoshi; Chamoto, Kenji; Honjo, Tasuku; Nakagawa, Kazuhiko; Ichikawa, Wataru; Fujii, Masashi
errShare
errSave
Agonistic anti-PD-1 antibodies downregulate autoantibody development in lupus model mice
err2023-05-01
err0
errOAAI
errTokumaru, Yosuke; Suzuki, Kensuke; Tajima, Masaki; Ohkura, Iori; Honjo, Tasuku; Ohta, Akio
errShare
errSave
Anti-PD-1 antibodies recognizing the membrane-proximal region are agonists that can stimulate immunosuppressive activity of PD-1
err2023-05-01
err0
errOAAI
errOhta, Akio; Suzuki, Kensuke; Tajima, Masaki; Tokumaru, Yosuke; Oshiro, Yuya; Nagata, Satoshi; Kamada, Haruhiko; Kihara, Miho; Nakano, Kohei; Honjo, Tasuku
errShare
errSave
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
err2023-04-25
err65
PREAI
errChamoto, Kenji; Yaguchi, Tomonori; Tajima, Masaki; Honjo, Tasuku
errShare
errSave
Chemically inducible splice-neoantigens for cancer immunotherapy
err2023-04-04
err0
PREAI
errMatsushima, Shingo; Ajiro, Masahiko; Iida, Kei; Chamoto, Kenji; Honjo, Tasuku; Hagiwara, Masatoshi
errShare
errSave
RBP-L, a transcription factor related to RBP-J kappa
err2023-03-29
err125
errOAAI
errMinoguchi, S; Taniguchi, Y; Kato, H; Okazaki, T; Strobl, LJ; ZimberStrobl, U; Bornkamm, GW; Honjo, T
errShare
errSave
HNRNPU facilitates antibody class-switch recombination through C-NHEJ promotion and R-loop suppression
err2023-03-01
err11
errOAAI
errRefaat, Ahmed M.; Nakata, Mikiyo; Husain, Afzal; Kosako, Hidetaka; Honjo, Tasuku; Begum, Nasim A.
errShare
errSave